Abstrakt: |
EXTON, Pa., June 24, 2019 /PRNewswire/ -- Immunome, a biotechnology company focused on discovering first-in-class therapeutics by leveraging the most highly educated components of the human immune system from cancer patients, announced today that industry veteran Purnanand Sarma, PhD, has joined Immunome as President and Chief Executive Officer. Sarma brings more than 25 years of industry experience with a proven track record in drug development, fund raising, and growing companies across multiple R&D platforms ranging from venture-backed biotechnology start-ups to large-cap pharmaceutical companies. Immunome's former Chief Executive Officer, Michael Morin, PhD, assumes the role of Chief Scientific Officer, allowing him to focus his time and expertise on maximizing the value of the company's proprietary breakthrough R&D engine. [ABSTRACT FROM PUBLISHER] |